Perceptive Advisors NAUT Position
ActivePerceptive Advisors held their position in Nautilus Biotechnology, Inc. (NAUT) in Q4 2025, holding $24.6M worth of shares across 12,594,211 shares.
The position was first reported in Q1 2023 and has been tracked across 12 quarterly 13F filings.
About Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
Full company profile →Short Interest
0.9%
1.9 days to cover
Perceptive Advisors NAUT Position History
| Quarter | Action | Shares | Change | Value |
|---|---|---|---|---|
| Q4 2025 | Held | 12,594,211 | — | $24.6M |
| Q3 2025 | Held | 12,594,211 | — | $10.6M |
| Q2 2025 | Held | 12,594,211 | — | $9.1M |
| Q1 2025 | Held | 12,594,211 | — | $10.8M |
| Q4 2024 | Held | 12,594,211 | — | $21.2M |
| Q3 2024 | Held | 12,594,211 | — | $35.9M |
| Q2 2024 | Held | 12,594,211 | — | $29.5M |
| Q1 2024 | Held | 12,594,211 | — | $37.0M |
| Q4 2023 | Increased | 12,594,211 | +3,483,060 | $37.7M |
| Q3 2023 | Held | 9,111,151 | — | $28.8M |
| Q2 2023 | Held | 9,111,151 | — | $35.3M |
| Q1 2023 | New | 9,111,151 | +9,111,151 | $25.2M |
Frequently Asked Questions
Does Perceptive Advisors own NAUT?
Yes. As of Q4 2025, Perceptive Advisors holds 12,594,211 shares of Nautilus Biotechnology, Inc. (NAUT) valued at $24.6M. This data comes from their SEC 13F filing.
How many hedge funds own NAUT?
1 specialist biotech hedge fund currently holds NAUT. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Perceptive Advisors first buy NAUT?
Perceptive Advisors's position in NAUT was first reported in Q1 2023. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Perceptive Advisors's NAUT position increasing or decreasing?
Perceptive Advisors held their NAUT position unchanged in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
NAUTCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Perceptive AdvisorsPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →